KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Procter & Gamble (PG) EBT (2016 - 2025)

Procter & Gamble (PG) has disclosed EBT for 17 consecutive years, with $5.4 billion as the latest value for Q4 2025.

  • On a quarterly basis, EBT fell 7.25% to $5.4 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $20.6 billion, a 6.12% increase, with the full-year FY2025 number at $20.2 billion, up 7.49% from a year prior.
  • EBT was $5.4 billion for Q4 2025 at Procter & Gamble, down from $6.0 billion in the prior quarter.
  • In the past five years, EBT ranged from a high of $6.0 billion in Q3 2025 to a low of $3.6 billion in Q2 2021.
  • A 5-year average of $4.7 billion and a median of $4.6 billion in 2024 define the central range for EBT.
  • Biggest YoY gain for EBT was 29.98% in 2024; the steepest drop was 11.41% in 2024.
  • Procter & Gamble's EBT stood at $5.2 billion in 2021, then fell by 7.71% to $4.8 billion in 2022, then dropped by 6.99% to $4.5 billion in 2023, then grew by 29.98% to $5.8 billion in 2024, then fell by 7.25% to $5.4 billion in 2025.
  • Per Business Quant, the three most recent readings for PG's EBT are $5.4 billion (Q4 2025), $6.0 billion (Q3 2025), and $4.5 billion (Q2 2025).